Screener
Janux Therapeutics JANX Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Janux Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Janux Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:18 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338078
FAQ
- What is Janux Therapeutics's net margin?
- Janux Therapeutics (JANX) reported net margin of -427.5% in Q2 2026.
- How has Janux Therapeutics's net margin changed year-over-year?
- Janux Therapeutics's net margin increased by 98.2% year-over-year, from -24,064% to -427.5%.
- What is the long-term trend for Janux Therapeutics's net margin?
- Over 4 years (2021 to 2025), Janux Therapeutics's net margin has grown at a 6.0% compound annual growth rate (CAGR), from -898.3% to -1,136.3%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Janux Therapeutics's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude